GEMINI-NSCLC: NSCLC Biomarker Study
Recruiting now
Conditions studied: Non-Small Cell Lung Cancer
In brief
GEMINI NSCLC Study is a non-interventional study that will be collecting clinical and molecular health information from patients with NSCLC who will receive longitudinal blood collection in addition to their standard of care therapy and disease surveillance with the goals of identifying the molecular evolution of lung cancer with standard of care therapy, and determining the utility of ctDNA dynamics to predict risk of recurrence and therapeutic outcomes.
Key facts
- Study ID
- NCT05236114
- Run by
- Tempus AI
- People needed
- 1200
- Starts
- 2022-06-22
- Expected to finish
- 2029-06-01
- Last updated by the study team
- 2026-02-05
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Oncology Hematology Associates — Springfield, Missouri, United States (enrolling)
- MemorialCare — Fountain Valley, California, United States (enrolling)
- Alabama Oncology — Birmingham, Alabama, United States (enrolling)
- UCLA — Los Angeles, California, United States (enrolling)
- Eastern CT and Hematology and Oncology Associates — Norwich, Connecticut, United States (enrolling)
- Clermont Oncology Center — Clermont, Florida, United States (enrolling)
- Mercy Clinic Oncology - Fort Smith — Fort Smith, Arkansas, United States (enrolling)
- Morehouse School of Medicine (MSM) — Atlanta, Georgia, United States (enrolling)
- Piedmont Healthcare — Atlanta, Georgia, United States (enrolling)
- Hawaii Cancer Care — Honolulu, Hawaii, United States (enrolling)
- Southern Illinois Hospital Services — Carterville, Illinois, United States (enrolling)
- Cancer Care Specialists of Illinois — Decatur, Illinois, United States (enrolling)
- Northwestern University — Evanston, Illinois, United States (enrolling)
- Hope and Healing Cancer Services — Hinsdale, Illinois, United States (enrolling)
- OSF Saint Anthony Medical Center — Rockford, Illinois, United States (enrolling)
- Community Health Network — Indianapolis, Indiana, United States (enrolling)
- University of Iowa — Iowa City, Iowa, United States (enrolling)
- University of Maryland — Baltimore, Maryland, United States (enrolling)
- Johns Hopkins University — Baltimore, Maryland, United States (enrolling)
- The Center for Cancer and Blood Disorder — Bethesda, Maryland, United States (enrolling)
- Frederick Health Regional System — Frederick, Maryland, United States (enrolling)
- Mercy Clinic Oncology and Hematology - Joplin — Joplin, Missouri, United States (enrolling)
- Lake Regional Health System — Osage Beach, Missouri, United States (enrolling)
- Mercy Clinic Cancer and Hematology - Chub O'Reilly Cancer Center — Springfield, Missouri, United States (enrolling)
- Mercy Clinic Oncology and Hematology - Sindelar Cancer Center — St Louis, Missouri, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.